Non-cardiac Chest Pain Treatment with Virtual Reality

Overview

About this study

The purpose of this study is to determine if virtual reality (VR) will improve symptoms in non-cardiac chest pain (NCCP).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Symptoms of non-cardiac chest pain (recurrent anginal-like or atypical chest pain).
  • Negative prior cardiac evaluation (at a minimum, including electrocardiogram).
  • Prior esophagogastroduodenoscopy and/or barium esophagram to rule out severe esophagitis, stricture, or motility abnormality.

Exclusion Criteria: 

  • Initiation of a proton pump inhibitor (PPI) within 8 weeks.
  • Major concomitant illness.
  • Current drug or alcohol use that that would interfere with adherence to study requirements.
  • Symptoms of vertigo or dizziness that would limit tolerability of the VR headset.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 12/20/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Andree Koop, M.D.

Open for enrollment

Contact information:

Wendi Lehman

(904) 953-8742

Lehman.Wendi@mayo.edu

More information

Publications

Publications are currently not available